Lercanidipine-13C,d3 hydrochloride

Modify Date: 2024-01-23 18:50:27

Lercanidipine-13C,d3 hydrochloride structure	Common Name	Lercanidipine-13C,d3 hydrochloride
	CAS Number	1261397-71-0	Molecular Weight	652.199
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₅₁₃CH₃₉D₃ClN₃O₆	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Lercanidipine-13C,d3 hydrochloride

Lercanidipine-13C,d3 (hydrochloride) is the deuterium and 13C labeled Lercanidipine hydrochloride[1]. Lercanidipine hydrochloride is a lipophilic third-generation dihydropyridine-calcium channel blocker (DHP-CCB). Lercanidipine hydrochloride has long lasting antihypertensive action and reno-protective effect[2][3][4].

Name	1-{(3,3-Diphenylpropyl)[(13C,2H3)methyl]amino}-2-methyl-2-propanyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate hydrochloride (1:1)
Synonym	More Synonyms

Description	Lercanidipine-13C,d3 (hydrochloride) is the deuterium and 13C labeled Lercanidipine hydrochloride[1]. Lercanidipine hydrochloride is a lipophilic third-generation dihydropyridine-calcium channel blocker (DHP-CCB). Lercanidipine hydrochloride has long lasting antihypertensive action and reno-protective effect[2][3][4].
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> Calcium Channel Research Areas >> Cardiovascular Disease
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Barrios, V., et al., Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study. Int J Clin Pract, 2006. 60(11): p. 1364-70. [3]. Burnier, M., M. Pruijm, and G. Wuerzner, Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine? Expert Opin Drug Metab Toxicol, 2009. 5(8): p. 981-7. [4]. Grassi G, et, al. Lercanidipine in the Management of Hypertension: An Update. J Pharmacol Pharmacother. Oct-Dec 20178(4):155-165.

Molecular Formula	C₃₅₁₃CH₃₉D₃ClN₃O₆
Molecular Weight	652.199
Exact Mass	651.298401

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-[(3,3-diphenylpropyl)methyl-13C-d3-amino]-1,1-dimethylethyl methyl ester, hydrochloride (1:1)

1-{(3,3-Diphenylpropyl)[(13C,2H3)methyl]amino}-2-methyl-2-propanyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate hydrochloride (1:1)

Lercanidipine-13C,d3 hydrochloride

Use of Lercanidipine-13C,d3 hydrochloride

Names

Lercanidipine-13C,d3 hydrochloride Biological Activity

Chemical & Physical Properties

Synonyms